Intangible outcomes from a policy change: using contingent valuation to quantify potential stigma from a cannabis offence
暂无分享,去创建一个
[1] S. Lenton,et al. Arrest, Court and Social Impacts of Conviction for a Minor Cannabis Offense under Strict Prohibition , 2000 .
[2] F. Carrat,et al. "If you have the flu symptoms, your asymptomatic spouse may better answer the willingness-to-pay question". Evidence from a double-bounded dichotomous choice model with heterogeneous anchoring. , 2009, Journal of health economics.
[3] Richard D. Smith,et al. It's not just what you do, it's the way that you do it: the effect of different payment card formats and survey administration on willingness to pay for health gain. , 2006, Health economics.
[4] Jeffrey M. Wooldridge,et al. Introductory Econometrics: A Modern Approach , 1999 .
[5] P. Reuter,et al. Cannabis Policy: Moving Beyond Stalemate , 2010 .
[6] P. Gruenewald,et al. Preventing Harmful Substance Use , 2005 .
[7] S. Mourato,et al. Cost-Benefit Analysis and the Environment: Recent Developments , 2006 .
[8] Richard D. Smith. Construction of the contingent valuation market in health care: a critical assessment. , 2003, Health economics.
[9] S. Galea,et al. Stigma, discrimination and the health of illicit drug users. , 2007, Drug and alcohol dependence.
[10] A. Boardman,et al. Cost-Benefit Analysis: Concepts and Practice , 1996 .
[11] Richard D. Smith,et al. The Discrete-choice Willingness-to-pay Question Format in Health Economics: , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[12] P. Cook,et al. The Benefits of Reducing Gun Violence: Evidence from Contingent-Valuation Survey Data , 1999 .
[13] J. Olsen,et al. Theory versus practice: a review of 'willingness-to-pay' in health and health care. , 2001, Health economics.
[14] J. J. R. Lott. An Attempt at Measuring the Total Monetary Penalty from Drug Convictions: The Importance of an Individual's Reputation , 1992, The Journal of Legal Studies.
[15] S. Lenton. Deterrence Theory and the Limitations of Criminal Penalties for Cannabis Use , 2009 .
[16] N. Hanley,et al. Cost–Benefit Analysis and the Environment , 1994 .
[17] C. Hughes,et al. A SUMMARY OF DIVERSION PROGRAMS FOR DRUG AND DRUG-RELATED OFFENDERS IN AUSTRALIA , 2008 .
[18] J. Dijk. The Narrow Margins of the Dutch Drug Policy: A Cost-Benefit Analysis , 1998 .
[19] K. Furuya. A socio-economic model of stigma and related social problems , 2002 .
[20] S. Fiske,et al. The Handbook of Social Psychology , 1935 .
[21] Nahid Golafshani,et al. Understanding Reliability and Validity in Qualitative Research , 2003 .
[22] Alex R. Piquero,et al. How Much is the Public Willing to Pay to be Protected from Identity Theft? , 2011 .
[23] D. McDonald,et al. The prohibition of illicit drugs is killing and criminalising our children and we are all letting it happen. , 2012 .
[24] M. Haden. Controlling illegal stimulants: a regulated market model , 2008, Harm reduction journal.
[25] Simon T. Tidd,et al. Willingness-to-Pay for Crime Control Programs , 2001 .
[26] A. Wodak,et al. Cannabis control: costs outweigh the benefits , 2002, BMJ : British Medical Journal.
[27] J. Borghi. Aggregation rules for cost-benefit analysis: a health economics perspective. , 2008, Health economics.
[28] Denzil G. Fiebig,et al. Consumers and experts: an econometric analysis of the demand for water heaters , 2006 .
[29] Jordan J. Louviere,et al. Applied Methods of Cost-Benefit Analysis in Health Care , 2010 .
[30] A. Vining,et al. An Assessment of Important Issues Concerning the Application of Benefit-Cost Analysis to Social Policy , 2010, Journal of Benefit-Cost Analysis.
[31] Giles Atkinson,et al. Valuing the costs of violent crime: a stated preference approach , 2005 .
[32] Aki Tsuchiya,et al. Estimating the Intangible Victim Costs of Violent Crime , 2005 .
[33] Patricia A. Champ,et al. Survey Methodologies for Stated-Choice Studies , 2006 .
[34] M. Krohn,et al. Labeling and Cumulative Disadvantage , 2012 .
[35] N. Powe,et al. Estimating the Value of Improved Street Lighting: A Factor Analytical Discrete Choice Approach , 2005 .
[36] A. Jacoby,et al. Felt versus enacted stigma: a concept revisited. Evidence from a study of people with epilepsy in remission. , 1994, Social science & medicine.
[37] J. Baker,et al. The Cannabis Cautioning Scheme Three Years On: An Implementation and Outcome Evaluation , 2004 .
[38] Søren Bøye Olsen,et al. Choosing Between Internet and Mail Survey Modes for Choice Experiment Surveys Considering Non-Market Goods , 2009 .
[39] M. Jones-Lee,et al. Valuation of Health Benefits Associated with Reductions in Air Pollution , 2004 .
[40] D. Pager. The Mark of a Criminal Record1 , 2003, American Journal of Sociology.
[41] Craig G. A. Jones,et al. Prohibition and Cannabis Use in Australia: A Survey of 18- to 29-year-olds , 2003 .
[42] Patricia Funk. On the effective use of stigma as a crime-deterrent , 2004 .
[43] A Gafni,et al. Health care contingent valuation studies: a review and classification of the literature. , 1998, Health economics.
[44] A. Hathaway,et al. Cannabis normalization and stigma: Contemporary practices of moral regulation , 2011 .
[45] U. Fischer. War on drugs , 2013 .
[46] Paul Dolan,et al. ESTIMATING THE ECONOMIC AND SOCIAL COSTS OF THE FEAR OF CRIME , 2007 .
[47] M. Johannesson,et al. Outcome measurement in economic evaluation. , 1996, Health economics.
[48] K. Upton,et al. A modern approach , 1995 .
[49] Emily Lancsar,et al. Choice experiments in health: the good, the bad, the ugly and toward a brighter future , 2009, Health Economics, Policy and Law.
[50] C. Hughes,et al. The effects of the decriminalization of drug use in Portugal , 2007 .
[51] D. Mcknight. Beyond Right and Left: New politics and the culture wars , 2005 .
[52] Richard D. Smith. Use, option and externality values: are contingent valuation studies in health care mis-specified? , 2007, Health economics.
[53] E. Rasmusen. Stigma and Self-Fulfilling Expectations of Criminality , 1996, The Journal of Law and Economics.
[54] Peter Abelson. Public Economics: Principles and Practice , 2008 .
[55] C. Lloyd. Sinning and Sinned Against: The Stigmatisation of Problem Drug Users , 2010 .